Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 50 of 137

    1.

    A common standard for conflict of interest disclosure in addiction journals.

    Goozner M, Caplan A, Moreno J, Kramer BS, Babor TF, Husser WC.

    Addiction. 2009 Nov;104(11):1779-84.PMID: 19832777 [PubMed - in process]Related articles

    2.

    American society of clinical oncology clinical practice guideline update on the use of pharmacologic interventions including tamoxifen, raloxifene, and aromatase inhibition for breast cancer risk reduction.

    Visvanathan K, Chlebowski RT, Hurley P, Col NF, Ropka M, Collyar D, Morrow M, Runowicz C, Pritchard KI, Hagerty K, Arun B, Garber J, Vogel VG, Wade JL, Brown P, Cuzick J, Kramer BS, Lippman SM; American Society of Clinical Oncology.

    J Clin Oncol. 2009 Jul 1;27(19):3235-58. Epub 2009 May 26.PMID: 19470930 [PubMed - indexed for MEDLINE]Related articles

    3.

    Cumulative incidence of false-positive results in repeated, multimodal cancer screening.

    Croswell JM, Kramer BS, Kreimer AR, Prorok PC, Xu JL, Baker SG, Fagerstrom R, Riley TL, Clapp JD, Berg CD, Gohagan JK, Andriole GL, Chia D, Church TR, Crawford ED, Fouad MN, Gelmann EP, Lamerato L, Reding DJ, Schoen RE.

    Ann Fam Med. 2009 May-Jun;7(3):212-22.PMID: 19433838 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Plausibility of stromal initiation of epithelial cancers without a mutation in the epithelium: a computer simulation of morphostats.

    Baker SG, Soto AM, Sonnenschein C, Cappuccio A, Potter JD, Kramer BS.

    BMC Cancer. 2009 Mar 23;9:89.PMID: 19309499 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Mortality results from a randomized prostate-cancer screening trial.

    Andriole GL, Crawford ED, Grubb RL 3rd, Buys SS, Chia D, Church TR, Fouad MN, Gelmann EP, Kvale PA, Reding DJ, Weissfeld JL, Yokochi LA, O'Brien B, Clapp JD, Rathmell JM, Riley TL, Hayes RB, Kramer BS, Izmirlian G, Miller AB, Pinsky PF, Prorok PC, Gohagan JK, Berg CD; PLCO Project Team.

    N Engl J Med. 2009 Mar 26;360(13):1310-9. Epub 2009 Mar 18. Erratum in: N Engl J Med. 2009 Apr 23;360(17):1797. PMID: 19297565 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    Use of 5-alpha-reductase inhibitors for prostate cancer chemoprevention: American Society of Clinical Oncology/American Urological Association 2008 Clinical Practice Guideline.

    Kramer BS, Hagerty KL, Justman S, Somerfield MR, Albertsen PC, Blot WJ, Ballentine Carter H, Costantino JP, Epstein JI, Godley PA, Harris RP, Wilt TJ, Wittes J, Zon R, Schellhammer P; American Society of Clinical Oncology Health Services Committee; American Urological Association Practice Guidelines Committee.

    J Clin Oncol. 2009 Mar 20;27(9):1502-16. Epub 2009 Feb 24. Review. Erratum in: J Clin Oncol. 2009 Jun 1;27(16):2742. PMID: 19252137 [PubMed - indexed for MEDLINE]Related articles

    7.

    Use of 5alpha-reductase inhibitors for prostate cancer chemoprevention: American Society of Clinical Oncology/American Urological Association 2008 Clinical Practice Guideline.

    Kramer BS, Hagerty KL, Justman S, Somerfield MR, Albertsen PC, Blot WJ, Carter HB, Costantino JP, Epstein JI, Godley PA, Harris RP, Wilt TJ, Wittes J, Zon R, Schellhammer P; American Society of Clinical Oncology/American Urological Association.

    J Urol. 2009 Apr;181(4):1642-57. Epub 2009 Feb 26. Review.PMID: 19249063 [PubMed - indexed for MEDLINE]Related articles

    8.

    Clinical trial design and evidence-based outcomes in the study of liver diseases.

    Croswell JM, Kramer BS.

    J Hepatol. 2009 Apr;50(4):817-26. Epub 2009 Feb 4. Review.PMID: 19231015 [PubMed - indexed for MEDLINE]Related articles

    9.

    American Society of Clinical Oncology policy statement: the role of the oncologist in cancer prevention and risk assessment.

    Zon RT, Goss E, Vogel VG, Chlebowski RT, Jatoi I, Robson ME, Wollins DS, Garber JE, Brown P, Kramer BS; American Society of Clinical Oncology.

    J Clin Oncol. 2009 Feb 20;27(6):986-93. Epub 2008 Dec 15.PMID: 19075281 [PubMed - indexed for MEDLINE]Related articles

    10.

    Prostate cancer screening in the Prostate, Lung, Colorectal and Ovarian cancer screening trial: update on findings from the initial four rounds of screening in a randomized trial.

    Grubb RL 3rd, Pinsky PF, Greenlee RT, Izmirlian G, Miller AB, Hickey TP, Riley TL, Mabie JE, Levin DL, Chia D, Kramer BS, Reding DJ, Church TR, Yokochi LA, Kvale PA, Weissfeld JL, Urban DA, Buys SS, Gelmann EP, Ragard LR, Crawford ED, Prorok PC, Gohagan JK, Berg CD, Andriole GL.

    BJU Int. 2008 Dec;102(11):1524-30.PMID: 19035857 [PubMed - indexed for MEDLINE]Related articles

    11.

    Early reporting for cancer screening trials.

    Baker SG, Kramer BS, Prorok PC.

    J Med Screen. 2008;15(3):122-9.PMID: 18927094 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Cancer screening: the clash of science and intuition.

    Kramer BS, Croswell JM.

    Annu Rev Med. 2009;60:125-37. Review.PMID: 18803476 [PubMed - indexed for MEDLINE]Related articles

    13.

    Design and endpoints of clinical trials in hepatocellular carcinoma.

    Llovet JM, Di Bisceglie AM, Bruix J, Kramer BS, Lencioni R, Zhu AX, Sherman M, Schwartz M, Lotze M, Talwalkar J, Gores GJ; Panel of Experts in HCC-Design Clinical Trials.

    J Natl Cancer Inst. 2008 May 21;100(10):698-711. Epub 2008 May 13. Review.PMID: 18477802 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Using microarrays to study the microenvironment in tumor biology: the crucial role of statistics.

    Baker SG, Kramer BS.

    Semin Cancer Biol. 2008 Oct;18(5):305-10. Epub 2008 Mar 26. Review.PMID: 18455427 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Five-alpha-reductase Inhibitors for prostate cancer prevention.

    Wilt TJ, MacDonald R, Hagerty K, Schellhammer P, Kramer BS.

    Cochrane Database Syst Rev. 2008 Apr 16;(2):CD007091. Review.PMID: 18425978 [PubMed - indexed for MEDLINE]Related articles

    16.

    Estimating the cumulative risk of a false-positive under a regimen involving various types of cancer screening tests.

    Baker SG, Kramer BS.

    J Med Screen. 2008;15(1):18-22.PMID: 18416950 [PubMed - indexed for MEDLINE]Related articles

    17.

    Clinical cancer advances 2007: major research advances in cancer treatment, prevention, and screening--a report from the American Society of Clinical Oncology.

    Gralow J, Ozols RF, Bajorin DF, Cheson BD, Sandler HM, Winer EP, Bonner J, Demetri GD, Curran W Jr, Ganz PA, Kramer BS, Kris MG, Markman M, Mayer RJ, Raghavan D, Ramsey S, Reaman GH, Sawaya R, Schuchter LM, Sweetenham JW, Vahdat LT, Davidson NE, Schilsky RL, Lichter AS; American Society of Clinical Oncology.

    J Clin Oncol. 2008 Jan 10;26(2):313-25. Epub 2007 Dec 17. Erratum in: J Clin Oncol. 2008 Mar 10;26(8):1394. PMID: 18086794 [PubMed - indexed for MEDLINE]Related articles

    18.

    Overstating the evidence for lung cancer screening: the International Early Lung Cancer Action Program (I-ELCAP) study.

    Welch HG, Woloshin S, Schwartz LM, Gordis L, Gøtzsche PC, Harris R, Kramer BS, Ransohoff DF.

    Arch Intern Med. 2007 Nov 26;167(21):2289-95.PMID: 18039986 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    Randomized trials for the real world: making as few and as reasonable assumptions as possible.

    Baker SG, Kramer BS.

    Stat Methods Med Res. 2008 Jun;17(3):243-52. Epub 2007 Oct 9. Review.PMID: 17925312 [PubMed - indexed for MEDLINE]Related articles

    20.

    Screening for prostate cancer: current status and future prospects.

    Sharifi N, Kramer BS.

    Am J Med. 2007 Sep;120(9):743-5. No abstract available. PMID: 17765037 [PubMed - indexed for MEDLINE]Related articles

    21.

    Paradoxes in carcinogenesis: new opportunities for research directions.

    Baker SG, Kramer BS.

    BMC Cancer. 2007 Aug 6;7:151.PMID: 17683619 [PubMed - indexed for MEDLINE]Related articlesFree article

    22.

    Prostate-specific antigen velocity and prostate cancer gleason grade and stage.

    Pinsky PF, Andriole G, Crawford ED, Chia D, Kramer BS, Grubb R, Greenlee R, Gohagan JK.

    Cancer. 2007 Apr 15;109(8):1689-95.PMID: 17330856 [PubMed - indexed for MEDLINE]Related articlesFree article

    23.

    Evidence of a healthy volunteer effect in the prostate, lung, colorectal, and ovarian cancer screening trial.

    Pinsky PF, Miller A, Kramer BS, Church T, Reding D, Prorok P, Gelmann E, Schoen RE, Buys S, Hayes RB, Berg CD.

    Am J Epidemiol. 2007 Apr 15;165(8):874-81. Epub 2007 Jan 22.PMID: 17244633 [PubMed - indexed for MEDLINE]Related articlesFree article

    24.

    Repeat prostate biopsy in the prostate, lung, colorectal and ovarian cancer screening trial.

    Pinsky PF, Crawford ED, Kramer BS, Andriole GL, Gelmann EP, Grubb R, Greenlee R, Gohagan JK.

    BJU Int. 2007 Apr;99(4):775-9. Epub 2007 Jan 12.PMID: 17223921 [PubMed - indexed for MEDLINE]Related articles

    25.

    Clinical cancer advances 2006: major research advances in cancer treatment, prevention, and screening--a report from the American Society of Clinical Oncology.

    Ozols RF, Herbst RS, Colson YL, Gralow J, Bonner J, Curran WJ Jr, Eisenberg BL, Ganz PA, Kramer BS, Kris MG, Markman M, Mayer RJ, Raghavan D, Reaman GH, Sawaya R, Schilsky RL, Schuchter LM, Sweetenham JW, Vahdat LT, Winn RJ; American Society of Clinical Oncology.

    J Clin Oncol. 2007 Jan 1;25(1):146-62. Epub 2006 Dec 8.PMID: 17158528 [PubMed - indexed for MEDLINE]Related articles

    26.

    Selecting patients for randomized trials: a systematic approach based on risk group.

    Vickers AJ, Kramer BS, Baker SG.

    Trials. 2006 Oct 5;7:30.PMID: 17022818 [PubMed]Related articlesFree article

    27.

    Identifying genes that contribute most to good classification in microarrays.

    Baker SG, Kramer BS.

    BMC Bioinformatics. 2006 Sep 7;7:407.PMID: 16959042 [PubMed - indexed for MEDLINE]Related articlesFree article

    28.

    Prostate volume and prostate-specific antigen levels in men enrolled in a large screening trial.

    Pinsky PF, Kramer BS, Crawford ED, Grubb RL, Urban DA, Andriole GL, Chia D, Levin DL, Gohagan JK.

    Urology. 2006 Aug;68(2):352-6.PMID: 16904451 [PubMed - indexed for MEDLINE]Related articles

    29.

    Getting it right: being smarter about clinical trials.

    Kramer BS, Wilentz J, Alexander D, Burklow J, Friedman LM, Hodes R, Kirschstein R, Patterson A, Rodgers G, Straus SE.

    PLoS Med. 2006 Apr;3(6):e144. No abstract available. PMID: 16608383 [PubMed - indexed for MEDLINE]Related articlesFree article

    30.

    Evaluating markers for the early detection of cancer: overview of study designs and methods.

    Baker SG, Kramer BS, McIntosh M, Patterson BH, Shyr Y, Skates S.

    Clin Trials. 2006;3(1):43-56. Review.PMID: 16539089 [PubMed - indexed for MEDLINE]Related articles

    31.

    Prostate specific antigen changes as related to the initial prostate specific antigen: data from the prostate, lung, colorectal and ovarian cancer screening trial.

    Crawford ED, Pinsky PF, Chia D, Kramer BS, Fagerstrom RM, Andriole G, Reding D, Gelmann EP, Levin DL, Gohagan JK.

    J Urol. 2006 Apr;175(4):1286-90; discussion 1290.PMID: 16515981 [PubMed - indexed for MEDLINE]Related articles

    32.

    Simple maximum likelihood estimates of efficacy in randomized trials and before-and-after studies, with implications for meta-analysis.

    Baker SG, Kramer BS.

    Stat Methods Med Res. 2005 Aug;14(4):349-67. Erratum in: Stat Methods Med Res. 2005 Dec;14(6):605. PMID: 16178137 [PubMed - indexed for MEDLINE]Related articles

    33.

    Simple adjustments for randomized trials with nonrandomly missing or censored outcomes arising from informative covariates.

    Baker SG, Fitzmaurice GM, Freedman LS, Kramer BS.

    Biostatistics. 2006 Jan;7(1):29-40. Epub 2005 May 27.PMID: 15923407 [PubMed - indexed for MEDLINE]Related articlesFree article

    34.

    Prostate Cancer Screening in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial: findings from the initial screening round of a randomized trial.

    Andriole GL, Levin DL, Crawford ED, Gelmann EP, Pinsky PF, Chia D, Kramer BS, Reding D, Church TR, Grubb RL, Izmirlian G, Ragard LR, Clapp JD, Prorok PC, Gohagan JK; PLCO Project Team.

    J Natl Cancer Inst. 2005 Mar 16;97(6):433-8.PMID: 15770007 [PubMed - indexed for MEDLINE]Related articlesFree article

    35.

    Prostate biopsy following a positive screen in the prostate, lung, colorectal and ovarian cancer screening trial.

    Pinsky PF, Andriole GL, Kramer BS, Hayes RB, Prorok PC, Gohagan JK; Prostate, Lung, Colorectal and Ovarian Project Team.

    J Urol. 2005 Mar;173(3):746-50; discussion 750-1.PMID: 15711261 [PubMed - indexed for MEDLINE]Related articles

    36.

    Cancer screening in theory and in practice.

    Brawley OW, Kramer BS.

    J Clin Oncol. 2005 Jan 10;23(2):293-300. Review.PMID: 15637392 [PubMed - indexed for MEDLINE]Related articles

    37.

    Final results of the Lung Screening Study, a randomized feasibility study of spiral CT versus chest X-ray screening for lung cancer.

    Gohagan JK, Marcus PM, Fagerstrom RM, Pinsky PF, Kramer BS, Prorok PC, Ascher S, Bailey W, Brewer B, Church T, Engelhard D, Ford M, Fouad M, Freedman M, Gelmann E, Gierada D, Hocking W, Inampudi S, Irons B, Johnson CC, Jones A, Kucera G, Kvale P, Lappe K, Manor W, Moore A, Nath H, Neff S, Oken M, Plunkett M, Price H, Reding D, Riley T, Schwartz M, Spizarny D, Yoffie R, Zylak C; LUNG SCREENING STUDY RESEARCH GROUP.

    Lung Cancer. 2005 Jan;47(1):9-15.PMID: 15603850 [PubMed - indexed for MEDLINE]Related articles

    38.

    Diagnostic procedures after a positive spiral computed tomography lung carcinoma screen.

    Pinsky PF, Marcus PM, Kramer BS, Freedman M, Nath H, Kvale P, Reding D.

    Cancer. 2005 Jan 1;103(1):157-63.PMID: 15529306 [PubMed - indexed for MEDLINE]Related articlesFree article

    39.

    The fallacy of enrolling only high-risk subjects in cancer prevention trials: is there a "free lunch"?

    Baker SG, Kramer BS, Corle D.

    BMC Med Res Methodol. 2004 Oct 4;4:24.PMID: 15461821 [PubMed - indexed for MEDLINE]Related articlesFree article

    40.

    Cancer prevention and the American Society of Clinical Oncology.

    Lippman SM, Levin B, Brenner DE, Gordon GB, Aldige CR, Kramer BS, Garber JE, Hawk E, Ganz PA, Somerfield MR; Writing Committee of the ASCO Cancer Prevention Committee.

    J Clin Oncol. 2004 Oct 1;22(19):3848-51. Epub 2004 Sep 7. No abstract available. PMID: 15353541 [PubMed - indexed for MEDLINE]Related articles

    41.

    Estimating the cumulative risk of a false-positive test in a repeated screening program.

    Xu JL, Fagerstrom RM, Prorok PC, Kramer BS.

    Biometrics. 2004 Sep;60(3):651-60.PMID: 15339287 [PubMed - indexed for MEDLINE]Related articles

    42.

    Development tracks for cancer prevention markers.

    Baker SG, Kramer BS, Prorok PC.

    Dis Markers. 2004;20(2):97-102. Review.PMID: 15322317 [PubMed - indexed for MEDLINE]Related articles

    43.

    The science of early detection.

    Kramer BS.

    Urol Oncol. 2004 Jul-Aug;22(4):344-7. Review.PMID: 15283894 [PubMed - indexed for MEDLINE]Related articles

    45.

    A perfect correlate does not a surrogate make.

    Baker SG, Kramer BS.

    BMC Med Res Methodol. 2003 Sep 9;3:16. Epub 2003 Sep 9.PMID: 12962545 [PubMed - indexed for MEDLINE]Related articlesFree article

    46.

    Estimating the cumulative risk of false positive cancer screenings.

    Baker SG, Erwin D, Kramer BS.

    BMC Med Res Methodol. 2003 Jul 3;3:11. Epub 2003 Jul 3.PMID: 12841854 [PubMed - indexed for MEDLINE]Related articlesFree article

    47.

    Randomized trials, generalizability, and meta-analysis: graphical insights for binary outcomes.

    Baker SG, Kramer BS.

    BMC Med Res Methodol. 2003 Jun 16;3:10. Epub 2003 Jun 16.PMID: 12809566 [PubMed - indexed for MEDLINE]Related articlesFree article

    48.

    Reported family history of cancer in the prostate, lung, colorectal, and ovarian cancer screening trial.

    Pinsky PF, Kramer BS, Reding D, Buys S; PLCO Project Team.

    Am J Epidemiol. 2003 May 1;157(9):792-9.PMID: 12727673 [PubMed - indexed for MEDLINE]Related articlesFree article

    49.

    Using observational data to estimate an upper bound on the reduction in cancer mortality due to periodic screening.

    Baker SG, Erwin D, Kramer BS, Prorok PC.

    BMC Med Res Methodol. 2003 Mar 6;3:4. Epub 2003 Mar 6.PMID: 12689345 [PubMed - indexed for MEDLINE]Related articlesFree article

    50.

    General keynote: cancer screening: translation of principles into practice.

    Kramer BS.

    Gynecol Oncol. 2003 Jan;88(1 Pt 2):S71-4; discussion S80-3. Review. No abstract available. PMID: 12586090 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data

    Search details

    » See more...